Fountain Life said that its Executive Health Membership Program delivers more than US$20 million in net benefit per 1,000 enrolled members annually, with a verified 13‑to‑1 return on investment over ten years.
Fountain Life reports that about 80 percent of participants achieve measurable health optimization within 1.3 to 1.8 years. The program—combining advanced AI‑guided diagnostics, precision imaging, and personalized health optimization—claims detection rates significantly higher than conventional screening: a 3 percent cancer detection rate (around four times the industry average) and a 3.5 percent aneurysm detection rate for conditions seldom caught by standard medical exams.
The company breaks down the financial impact per 1,000 members as follows: $2.45 million saved by early disease treatment, $8.9 million from avoiding advanced‑disease costs, $1.65 million from preserved productivity, $3.2 million through long-term healthcare savings, and additional wellness optimization gains—totaling over $20 million net benefit annually.
Beyond cost savings, Fountain Life claims substantial improvements in health metrics across its members. Reported changes include a 12 percent regression in cardiovascular plaque buildup, 56 percent improvement in deep white‑matter brain lesions, 46 percent reversal of accelerated brain aging, 52 percent normalization of liver fat, and 63 percent restoration of optimal nutrient levels—typically within 18 months.
Fountain Life offers its Executive Health Membership in two tiers: the “CORE” plan (full‑body MRI, cardiac, metabolic, neurocognitive screening) and the “APEX” plan (adding genomic/epigenetic mapping, continuous AI biomarker monitoring, and personalized longevity coaching).
The company argues that these results show preventive health and optimization can shift from being a cost item to a value‑creating asset—by protecting human capital, improving long‑term health, and boosting organizational resilience.
